The FDA's new genAI-assisted scientific review technology, named Elsa, was officially adopted by the agency on 2 June.

Dubbed Elsa, the tool was expected to roll out at the end of June. The FDA says it marks the dawn of a new era.

The Food and Drug Administration has officially launched "Elsa," a generative artificial intelligence platform designed to ...

The FDA regulates products that account for one-fifth of American consumer spending—everything from lettuce to vapes to pet ...

Qualifying manufacturers will be able to submit some data while clinical trials are ongoing. Marty Makary is the commissioner ...

Learn more about the generative AI technology that will be used at the Food and Drug Administration (FDA) to speed up reviews ...

The Food and Drug Administration has gone all in on AI since Martin Makary, M.D., took over the agency, most recently ...

WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) says it plans to use artificial ...

With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...

The FDA has launched a pilot program using generative AI to help expedite the review of drug and device applications, part of a sweeping modernization effort by the agency. The initiative, led by FDA ...

Elsa” is the FDA’s new anthropomorphized AI tool which, the FDA hopes, will speed up clearances, licenses, and approvals ...